Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
Guidance Documents/Guidance-Document/Q3B(R) Impurities in New Drug Products (Revision 3)

Q3B(R) Impurities in New Drug Products (Revision 3)

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

August 4, 2006

September 29, 2021

Center for Drug Evaluation and Research

a2e10295-fed5-4751-9af6-54da8d5c29c3

Related Documents

M4: The CTD -- Efficacy Questions and Answers

Guidance DocumentDecember 1, 2004Center for Drug Evaluation and Research
View Details →

Q1A(R2) Stability Testing of New Drug Substances and Products

Guidance DocumentNovember 21, 2003Center for Drug Evaluation and Research
View Details →

M4: The CTD -- General Questions and Answers

Guidance DocumentDecember 22, 2004Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.